Keep up to date with the latest news about IDEA, including the initiative's workshops, events and publications
On 12 December 2018 IDEA held a Workshop on the Characterization and Categorization of allergens, at the Hotel Dominican, Brussels.
On 9 January 2019 a Joint Meeting of the IDEA Supervisory Group (SG) and the IDEA Management Team took place in London.
IDEA's work on a market surveillance study on Limonene and Linalool hydroperoxides in finished consumer products has been published in Food and Chemical Toxicology.
The European Parliament in Brussels hosts the fifth Annual Review of the IDEA Project on 25 February 2019.
IDEA experts reunited on 12 December 2018 in Brussels to continue the discussion on Characterization and Categorization (C&C) of fragrance allergens.
On Friday 19 October, 2018, IDEA hosted an Industry Symposium session at the European Society of Contact Dermatitis (ESCD) Congress in Milan, Italy.
During a 'Petit WPC' session on 7 June 2018 at the World Perfumery Congress, a panel of experts discussed how The International Dialogue for the Evaluation of Allergens (IDEA) developed a global framework for assessing fragrance sensitizers through various partnerships and collaborations.
The International Dialogue for the Evaluation of Allergens (IDEA) held a Workshop on 16-17 May looking at the replacement of animal testing in quantitative risk assessment (QRA) for skin sensitisation.
The International Dialogue for the Evaluation of Allergens (IDEA) welcomes the publication of a Draft Opinion on Skin Sensitization Quantitative Risk Assessment for Fragrance Ingredients (QRA2).
Under the framework of IDEA, a revised methodlogy on Quantitative Risk Assessment (QRA2) has been developped. This revised methodlogy focuses on total exposure of consumers to individual fragrances.
The IDEA Management Team met representatives of the European Commission’s Joint Research Centre (JRC) on 28 June in Ispra, Italy.
Every year, since this is a long-term project, an Annual Review takes place to monitor and validate progress and update the program and priorities when needed and to ensure that all scientific stakeholders can express their views and get further clarification on the project.